To select the compounds that can actually induce downregulation of HER2 in cancer cells, we applied the top 12 compounds with the highest SEAP inhibitory activity to NCI-N87, a well-known HER2-positive gastric cancer cell line, and evaluated changes in the HER2 protein expression level (Figure 3C). The gene discussed is ERBB2; the disease is gastric cancer.